These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3904987)

  • 1. In vitro systems to study organ and species differences in the metabolic activation of chemical carcinogens.
    Langenbach R
    Carcinog Compr Surv; 1985; 10():135-46. PubMed ID: 3904987
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenesis, clastogenesis, carcinogenesis: expectations, correlations and relations.
    Zeiger E; Tennant RW
    Prog Clin Biol Res; 1986; 209B():75-84. PubMed ID: 3529117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro mammalian cell genotoxicity assays: their use and interpretation.
    McGregor D
    Prog Clin Biol Res; 1990; 340B():159-69. PubMed ID: 2203003
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of mutagenicity test systems in protection of the water supply].
    Irmer H; Lehmann M
    Schriftenr Ver Wasser Boden Lufthyg; 1985; 65():255-61. PubMed ID: 3914072
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic activation of carcinogens in the Salmonella mutagenicity assay by hamster and rat liver S-9 preparations.
    Raineri R; Poiley JA; Pienta RJ; Andrews AW
    Environ Mutagen; 1981; 3(1):71-84. PubMed ID: 7021144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prospects for the use of short-term tests in primary cancer prevention].
    Khudoleĭ VV; Pliss GB
    Vopr Onkol; 1984; 30(8):3-12. PubMed ID: 6385476
    [No Abstract]   [Full Text] [Related]  

  • 7. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutagenicity study of butachlor and its metabolites using Salmonella typhimurium.
    Hsu KY; Lin HJ; Lin JK; Kuo WS; Ou YH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):409-16. PubMed ID: 16341341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activation of procarcinogens by subcellular enzyme fractions in the C3H 10T1/2 and BALB/c 3T3 cell transformation systems.
    Schechtman LM
    IARC Sci Publ; 1985; 67():137-62. PubMed ID: 3913640
    [No Abstract]   [Full Text] [Related]  

  • 10. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium.
    Oglesby LA; Hix C; Snow L; MacNair P; Seig M; Langenbach R
    Cancer Res; 1983 Nov; 43(11):5194-9. PubMed ID: 6352016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity studies of benzalazine.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1366-8. PubMed ID: 7848359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is pulsed ultrasound mutagenic?
    Barnett SB; Baker RS; Barnstable S
    Ultrasound Med Biol; 1983; Suppl 2():45-8. PubMed ID: 6400263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of short-term tests for carcinogenicity.
    Lave LB; Omenn GS
    Nature; 1986 Nov 6-12; 324(6092):29-34. PubMed ID: 3097548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    IARC Sci Publ; 1980; (27):179-241. PubMed ID: 7002778
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test system: metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster, and man.
    Wirth PJ; Dybing E; von Bahr C; Thorgeirsson SS
    Mol Pharmacol; 1980 Jul; 18(1):117-27. PubMed ID: 6997726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.